Alzheimer's Drug Donanemab Helps Most When Taken Early in Disease
An Alzheimer’s drug that attacks the protein amyloid does not work as well in people with more advanced disease
Stay updated with breaking news from Mark Mintun. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An Alzheimer’s drug that attacks the protein amyloid does not work as well in people with more advanced disease
Some public health experts worry the FDA has set impossible standards for menthol vapes.
Participants were able to stop treatment after achieving amyloid plaque clearance and experience lasting results.
A landmark trial has shown that a drug called donanemab has significantly halted brain deterioration - only the second drug ever proven to do so - in a breakthrough for Alzheimer's research
A new drug has been found to slow the progression of Alzheimer's, with experts hailing it as a turning point in the fight against the disease.